Back to top

zacks-consensus-estimate: Archive

Zacks Equity Research

Limbach (LMB) Upgraded to Buy: Here's Why

Limbach (LMB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

LMBNegative Net Change

Zacks Equity Research

All You Need to Know About Holley (HLLY) Rating Upgrade to Buy

Holley (HLLY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

HLLYNegative Net Change

Zacks Equity Research

Powell Industries (POWL) Upgraded to Buy: Here's What You Should Know

Powell Industries (POWL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

POWLNegative Net Change

Zacks Equity Research

What Makes OppFi (OPFI) a New Buy Stock

OppFi (OPFI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

OPFINegative Net Change

Zacks Equity Research

Analysts Estimate Flowers Foods (FLO) to Report a Decline in Earnings: What to Look Out for

Flowers Foods (FLO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FLONegative Net Change

Zacks Equity Research

BitFuFu Inc. (FUFU) Earnings Expected to Grow: Should You Buy?

BitFuFu Inc. (FUFU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FUFUNegative Net Change CANNegative Net Change

Zacks Equity Research

How Much Upside is Left in Tidewater (TDW)? Wall Street Analysts Think 31.5%

The consensus price target hints at a 31.5% upside potential for Tidewater (TDW). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

TDWPositive Net Change

Zacks Equity Research

How Much Upside is Left in Hesai Group Sponsored ADR (HSAI)? Wall Street Analysts Think 27.28%

The average of price targets set by Wall Street analysts indicates a potential upside of 27.3% in Hesai Group Sponsored ADR (HSAI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

HSAIPositive Net Change

Zacks Equity Research

Can InfuSystems Holdings (INFU) Climb 79.52% to Reach the Level Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 79.5% in InfuSystems Holdings (INFU). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

INFUPositive Net Change

Zacks Equity Research

Wall Street Analysts See a 32.98% Upside in Great Lakes Dredge & Dock (GLDD): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 33% in Great Lakes Dredge & Dock (GLDD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

GLDDNegative Net Change

Zacks Equity Research

Wall Street Analysts Believe Genmab (GMAB) Could Rally 33.8%: Here's is How to Trade

The mean of analysts' price targets for Genmab (GMAB) points to a 33.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

GMABPositive Net Change

Zacks Equity Research

Wall Street Analysts Think Contineum Therapeutics, Inc. (CTNM) Could Surge 235.81%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 235.8% in Contineum Therapeutics, Inc. (CTNM). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

CTNMPositive Net Change

Zacks Equity Research

Strawberry Fields REIT, Inc. (STRW) Q2 FFO and Revenues Beat Estimates

Strawberry Fields REIT, Inc. (STRW) delivered FFO and revenue surprises of +406.67% and +0.86%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

STRWPositive Net Change NKSHNegative Net Change

Zacks Equity Research

Wall Street Analysts See a 55.87% Upside in Superior Group (SGC): Can the Stock Really Move This High?

The consensus price target hints at a 55.9% upside potential for Superior Group (SGC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

SGCNegative Net Change

Zacks Equity Research

Wall Street Analysts Believe Sky Harbour Group (SKYH) Could Rally 72.97%: Here's is How to Trade

The consensus price target hints at a 73% upside potential for Sky Harbour Group (SKYH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

SKYHNegative Net Change

Zacks Equity Research

Does Remitly Global (RELY) Have the Potential to Rally 43.06% as Wall Street Analysts Expect?

The consensus price target hints at a 43.1% upside potential for Remitly Global (RELY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

RELYNegative Net Change

Zacks Equity Research

Hudson Global (HSON) Q2 Earnings Miss Estimates

Hudson Global (HSON) delivered earnings and revenue surprises of -29.41% and +3.38%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

HSONPositive Net Change IBTAPositive Net Change

Zacks Equity Research

Alphabet (GOOGL) Boasts Earnings & Price Momentum: Should You Buy?

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.

GOOGLPositive Net Change

Zacks Equity Research

Why This 1 Computer and Technology Stock Could Be a Great Addition to Your Portfolio

The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

PLTRNegative Net Change

Zacks Equity Research

American Axle & Manufacturing (AXL) Surpasses Q2 Earnings and Revenue Estimates

American Axle (AXL) delivered earnings and revenue surprises of +61.54% and +2.07%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

AXLNegative Net Change INVZPositive Net Change

Zacks Equity Research

Koppers (KOP) Q2 Earnings and Revenues Miss Estimates

Koppers (KOP) delivered earnings and revenue surprises of -0.67% and -9.42%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

KOPNegative Net Change FSINegative Net Change

Zacks Equity Research

Heron Therapeutics (HRTX) Reports Q2 Loss, Misses Revenue Estimates

Heron Therapeutics (HRTX) delivered earnings and revenue surprises of -100.00% and -1.89%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

HRTXNegative Net Change LYRANegative Net Change

Zacks Equity Research

fuboTV Inc. (FUBO) Q2 Earnings and Revenues Beat Estimates

fuboTV (FUBO) delivered earnings and revenue surprises of +150.00% and +1.34%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

FUBONegative Net Change IHRTNegative Net Change

Zacks Equity Research

PAR Technology (PAR) Q2 Earnings Lag Estimates

PAR Technology (PAR) delivered earnings and revenue surprises of -25.00% and +4.14%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

PARPositive Net Change PAGSPositive Net Change

Zacks Equity Research

Alpha Metallurgical (AMR) Reports Q2 Loss, Misses Revenue Estimates

Alpha Metallurgical (AMR) delivered earnings and revenue surprises of +84.03% and -3.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

AMRNegative Net Change SZGPYPositive Net Change